Alerje

Alerje, a Detroit-based digital health company founded in 2016, is focused on the food allergy market. The company was established by Javier Evelyn, who has personally contended with multiple severe food allergies since childhood. His experiences, coupled with a professional background that includes leading mobile app projects for a major health insurance provider and co-founding an independent insurance agency, directly inform the company's mission. Alerje is developing a multi-faceted platform to improve the quality of life for individuals with life-threatening food allergies.

The core of Alerje's offering is a platform that combines a patented medical device with a software application. The physical product, known as the Omniject, is an epinephrine auto-injector designed to be integrated into a smartphone case. This design addresses the common challenges of patients forgetting or being reluctant to carry the traditionally bulky auto-injectors. When the injector is removed from its case, the system is designed to automatically send alerts to a predefined support circle, including family and first responders, providing critical information in an emergency. This integration of emergency medicine with digital health tools aims to improve patient adherence and emergency response times.

Beyond the emergency device, Alerje's business model incorporates a software-as-a-service (SaaS) component targeted at patients, caregivers, and healthcare providers. The company has developed a mobile application that supports daily allergy management through features like food label scanners, allergen-safe recipes, and medication expiration reminders. A significant focus is on supporting patients undergoing Oral Immunotherapy (OIT). With backing from the National Science Foundation, Alerje created a remote patient monitoring platform that uses a machine learning algorithm to track patient progress, adherence, and behavioral health data during OIT, aiming to predict treatment outcomes and enhance care strategies for allergists. Revenue generation is anticipated through subscription fees for advanced app features, in-app purchases, and strategic partnerships with healthcare providers, insurers, and pharmaceutical companies.

Keywords: food allergy management, digital health, epinephrine auto-injector, patient adherence, remote patient monitoring, oral immunotherapy, MedTech, emergency response, AI in healthcare, allergy care